Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Biosimilars have been in clinical use for more than 10 years, and evidence from more than 700 million patient-days’ exposure shows that approved biosimilars can be used as safely and effectively as their originator biologics. And yet concerns about these drugs persist, particularly in therapy areas where they are recent additions to the formulary. It is vital to address these concerns so that clinicians can prescribe biosimilars with confidence, realizing substantial cost savings and improving patient access to effective treatments. 'Fast Facts: Biosimilars' provides a comprehensive yet concise explanation of biosimilars: what they are, how they are regulated, and how they are used in clinical practice. It is ideal for healthcare professionals and decision makers who want to understand biosimilars and the key concerns and controversies around these valuable products. Contents: 1 - An introduction to biologics and biosimilars 2 - Why do we need biosimilars? 3 - How is the quality of biosimilars assured? 4 - How is the efficacy and safety of biosimilars ensured? 5 - What has been the experience with biosimilars to date? 6 - The future of biosimilar medicines 7 - How do I use biosimilar medicines?

Pharmaceutical biotechnology. --- Biopharmaceutical technology --- Drugs --- Biotechnology --- Pharmaceutical technology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Microfluidics for Pharmaceutical Applications: From Nano/Micro Systems Fabrication to Controlled Drug Delivery is a concept-orientated reference that features case studies on utilizing microfluidics for drug delivery applications. It is a valuable learning reference on microfluidics for drug delivery applications and assists practitioners developing novel drug delivery platforms using microfluidics. It explores advances in microfluidics for drug delivery applications from different perspectives, covering device fabrication, fluid dynamics, cutting-edge microfluidic technology in the global drug delivery industry, lab-on-chip nano/micro fabrication and drug encapsulation, cell encapsulation and delivery, and cell- drug interaction screening"--Publisher.

Microfluidics. --- Pharmaceutical biotechnology. --- Biopharmaceutical technology --- Drugs --- Biotechnology --- Pharmaceutical technology --- Fluidics --- Nanofluids

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

For many people, biotechnology means genetically modifi ed organisms, alien species, toxic weapons or hormone-treated beef. Yet it is also a tool to control plant and animal pests, pre-serve species, utilize genetic resources for health and nutrition and protect the environment. Society's ability to manage, share and regulate advanced biotechnology offers many opportu-nities and raises many challenges and risks.This book explores the issues of advanced biotechnology and examines the progress made in recent years. It looks at the drivers of medical and pharmaceutical biotechnology develop-ment

Biotechnology. --- Biotechnology industries. --- Pharmaceutical biotechnology. --- Biopharmaceutical technology --- Drugs --- Biotechnology --- Chemical engineering --- Genetic engineering --- Pharmaceutical technology --- Biomedical industries --- High technology industries

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals comprehensively reviews current information on nanotechnology applied to phytochemical nanoencapsulation to enhance their bioavailability and bioactivity. The book is divided into two sections, the first section critically reviews current information on the field of nanotechnology and phytochemicals, and the second section highlights the pre-clinical and clinical studies of phytochemicals to comprehensively review the efficacy of these molecules as drugs of human use. Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals provides a useful overview of this rapidly evolving field for materials scientists and pharmaceutical scientists, as well as for those with an interest in biopharmaceuticals from plant sources, such as organic chemists and food scientists. Provides an introduction to both phytochemicals and nanomaterials for use in biopharmaceutics, allowing both materials scientists and pharmaceutical scientists to gain a basic understanding of each field Reviews key phytochemical types for use as biopharmaceuticals, including terpenes, alkaloids, glucosinolates and more Explores the various nanomaterials and nanoencapsulation techniques for administration of phytochemical nanoformulations.

Nanomedicine. --- Pharmaceutical biotechnology. --- Biopharmaceutical technology --- Drugs --- Biotechnology --- Pharmaceutical technology --- Medicine --- Nanotechnology --- Nanoparticle Drug Delivery System. --- Phytochemicals --- Biopharmaceutics. --- therapeutic use.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Delivery of therapeutic proteomics and genomics represent an important area of drug delivery research. Genomics and proteomics approaches could be used to direct drug development processes by unearthing pathways involved in disease pathogenesis where intervention may be most successful. This book describes the basics of genomics and proteomics and highlights the various chemical, physical and biological approaches to protein and gene delivery. Covers a diverse array of topics from basic sciences to therapeutic applications of proteomics and genomics delivery<

Drug delivery systems. --- Pharmaceutical biotechnology. --- Biopharmaceutical technology --- Drugs --- Biotechnology --- Pharmaceutical technology --- Delivery systems, Drug --- Drug administration technology --- Drug delivery technology --- Delivery systems